Observational studyCancer research and treatment2025

Real-World Effectiveness and Safety of Intravenous Daratumumab in Patients with Multiple Myeloma: A Multicenter, Observational Study from Korea.

Youngil Koh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.